Press Release Details

View all news

Bruker Corporation to Present at Investor Conferences

August 31, 2016

BILLERICA, Mass., Aug. 31, 2016 /PRNewswire/ -- Bruker Corporation (NASDAQ: BRKR) announced today it will present at the following conferences:

Wells Fargo 2016 Healthcare Conference
Wednesday, September 7, 2016, at 9:55 a.m. Eastern Time
Westin Waterfront Hotel, Boston, MA
Frank Laukien, President and Chief Executive Officer
Tony Mattacchione, Senior Vice President and Chief Financial Officer

Morgan Stanley Global Healthcare Conference
Monday, September 12, 2016, at 11:05 a.m. Eastern Time
Grand Hyatt Hotel, New York City, NY
Stacey Desrochers, Treasurer and Director of Investor Relations

A live audio webcast of both presentations will be available on the Investor section of the Company's Web site at Replays of the presentations will be posted on the Bruker Corporation website after the event and will be available for 30 days following the presentations.

About Bruker Corporation

For more than 50 years, Bruker has enabled scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker's high-performance scientific research instruments and high-value analytical solutions enable scientists to explore life and materials at molecular, cellular and microscopic levels. 

In close cooperation with our customers, Bruker is enabling innovation, productivity and customer success in life science molecular research, in applied and pharma applications, and in microscopy, nano-analysis and industrial applications, as well as in cell biology, preclinical imaging, clinical research, microbiology and molecular diagnostics. For more information, please visit:

Stacey Desrochers                                                                                           
Treasurer and Director of Investor Relations
Bruker Corporation                                                                   
T: +1 (978) 663 – 3660, ext. 1115                                                                                                                                                 

To view the original version on PR Newswire, visit:

SOURCE Bruker Corporation

Categories: Press Releases
View all news